Peter Bains, Group CEO of Biocon, talks about India's budget, and the impact of its plans to cut or remove duties on ...

India's Divi's Laboratories reported a better-than-expected quarterly profit on Monday, aided by strong performance of its business that focuses on customised production of chemical compounds used in ...

Indian drugmaker Alembic Pharmaceuticals reported a lower third-quarter profit on Monday, weighed down by weak local sales of its drugs that treat acute illnesses.

New Delhi: Finance Minister Nirmala Sitharaman announced a full exemption from basic customs duty (BCD) for 36 live-saving ...

India's pharmaceutical industry is set for growth, driven by strong market players, global reputation, and evolving trends.

Qartemi is a 'living drug' that has been approved by the Central Drugs Standard Control Organisation (CDSCO) for blood cancer ...

Leading global drugmakers such as MSD Pharmaceuticals, Novartis, AstraZeneca, and Pfizer stand to benefit as it opens new ...

GV Research Platform (GVRP), a leading provider of preclinical research solutions, has announced a strategic partnership with ...

Why I withdrew a petition questioning the approval to three drugs that continue to be sold on the Indian market despite ...

The Research was led by the Institute's Centre of Excellence on Cancer Genomics and Molecular Therapeutics, which was funded ...

The government's decision to exempt 36 life-saving drugs for cancer, and chronic diseases from basic customs duty is a ...